2018-2023 Global Vaccine for Non-infectious Meningitis Consumption Market Report

October 2018 | 139 pages | ID: 2CA754A94A2EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Vaccine for Non-infectious Meningitis market for 2018-2023.

Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
Over the next five years, LPI(LP Information) projects that Vaccine for Non-infectious Meningitis will register a 12.3% CAGR in terms of revenue, reach US$ 2 million by 2023, from US$ 1 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine for Non-infectious Meningitis market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Polysaccharide Vaccines
• Conjugate Vaccines
• Combination Vaccines
• Men B Vaccines

Segmentation by application:

• Meningitis
• Septicemia
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Serum Institute (India)
• Sanofi SA (France)
• Pfizer (USA)
• Nuron Biotech (USA)
• JN-International Medical (USA)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Vaccine for Non-infectious Meningitis consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Vaccine for Non-infectious Meningitis market by identifying its various subsegments.
• Focuses on the key global Vaccine for Non-infectious Meningitis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Vaccine for Non-infectious Meningitis with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Vaccine for Non-infectious Meningitis submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vaccine for Non-infectious Meningitis Consumption 2013-2023
  2.1.2 Vaccine for Non-infectious Meningitis Consumption CAGR by Region
2.2 Vaccine for Non-infectious Meningitis Segment by Type
  2.2.1 Polysaccharide Vaccines
  2.2.2 Conjugate Vaccines
  2.2.3 Combination Vaccines
  2.2.4 Men B Vaccines
2.3 Vaccine for Non-infectious Meningitis Consumption by Type
  2.3.1 Global Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
  2.3.2 Global Vaccine for Non-infectious Meningitis Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Vaccine for Non-infectious Meningitis Sale Price by Type (2013-2018)
2.4 Vaccine for Non-infectious Meningitis Segment by Application
  2.4.1 Meningitis
  2.4.2 Septicemia
  2.4.3 Others
2.5 Vaccine for Non-infectious Meningitis Consumption by Application
  2.5.1 Global Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
  2.5.2 Global Vaccine for Non-infectious Meningitis Value and Market Share by Application (2013-2018)
  2.5.3 Global Vaccine for Non-infectious Meningitis Sale Price by Application (2013-2018)

3 GLOBAL VACCINE FOR NON-INFECTIOUS MENINGITIS BY PLAYERS

3.1 Global Vaccine for Non-infectious Meningitis Sales Market Share by Players
  3.1.1 Global Vaccine for Non-infectious Meningitis Sales by Players (2016-2018)
  3.1.2 Global Vaccine for Non-infectious Meningitis Sales Market Share by Players (2016-2018)
3.2 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Players
  3.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Players (2016-2018)
  3.2.2 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Players (2016-2018)
3.3 Global Vaccine for Non-infectious Meningitis Sale Price by Players
3.4 Global Vaccine for Non-infectious Meningitis Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Vaccine for Non-infectious Meningitis Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Vaccine for Non-infectious Meningitis Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 VACCINE FOR NON-INFECTIOUS MENINGITIS BY REGIONS

4.1 Vaccine for Non-infectious Meningitis by Regions
  4.1.1 Global Vaccine for Non-infectious Meningitis Consumption by Regions
  4.1.2 Global Vaccine for Non-infectious Meningitis Value by Regions
4.2 Americas Vaccine for Non-infectious Meningitis Consumption Growth
4.3 APAC Vaccine for Non-infectious Meningitis Consumption Growth
4.4 Europe Vaccine for Non-infectious Meningitis Consumption Growth
4.5 Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Growth

5 AMERICAS

5.1 Americas Vaccine for Non-infectious Meningitis Consumption by Countries
  5.1.1 Americas Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018)
  5.1.2 Americas Vaccine for Non-infectious Meningitis Value by Countries (2013-2018)
5.2 Americas Vaccine for Non-infectious Meningitis Consumption by Type
5.3 Americas Vaccine for Non-infectious Meningitis Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Vaccine for Non-infectious Meningitis Consumption by Countries
  6.1.1 APAC Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018)
  6.1.2 APAC Vaccine for Non-infectious Meningitis Value by Countries (2013-2018)
6.2 APAC Vaccine for Non-infectious Meningitis Consumption by Type
6.3 APAC Vaccine for Non-infectious Meningitis Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Vaccine for Non-infectious Meningitis by Countries
  7.1.1 Europe Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018)
  7.1.2 Europe Vaccine for Non-infectious Meningitis Value by Countries (2013-2018)
7.2 Europe Vaccine for Non-infectious Meningitis Consumption by Type
7.3 Europe Vaccine for Non-infectious Meningitis Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vaccine for Non-infectious Meningitis by Countries
  8.1.1 Middle East & Africa Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Vaccine for Non-infectious Meningitis Value by Countries (2013-2018)
8.2 Middle East & Africa Vaccine for Non-infectious Meningitis Consumption by Type
8.3 Middle East & Africa Vaccine for Non-infectious Meningitis Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Vaccine for Non-infectious Meningitis Distributors
10.3 Vaccine for Non-infectious Meningitis Customer

11 GLOBAL VACCINE FOR NON-INFECTIOUS MENINGITIS MARKET FORECAST

11.1 Global Vaccine for Non-infectious Meningitis Consumption Forecast (2018-2023)
11.2 Global Vaccine for Non-infectious Meningitis Forecast by Regions
  11.2.1 Global Vaccine for Non-infectious Meningitis Forecast by Regions (2018-2023)
  11.2.2 Global Vaccine for Non-infectious Meningitis Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Vaccine for Non-infectious Meningitis Forecast by Type
11.8 Global Vaccine for Non-infectious Meningitis Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Serum Institute (India)
  12.1.1 Company Details
  12.1.2 Vaccine for Non-infectious Meningitis Product Offered
  12.1.3 Serum Institute (India) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Serum Institute (India) News
12.2 Sanofi SA (France)
  12.2.1 Company Details
  12.2.2 Vaccine for Non-infectious Meningitis Product Offered
  12.2.3 Sanofi SA (France) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Sanofi SA (France) News
12.3 Pfizer (USA)
  12.3.1 Company Details
  12.3.2 Vaccine for Non-infectious Meningitis Product Offered
  12.3.3 Pfizer (USA) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Pfizer (USA) News
12.4 Nuron Biotech (USA)
  12.4.1 Company Details
  12.4.2 Vaccine for Non-infectious Meningitis Product Offered
  12.4.3 Nuron Biotech (USA) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Nuron Biotech (USA) News
12.5 JN-International Medical (USA)
  12.5.1 Company Details
  12.5.2 Vaccine for Non-infectious Meningitis Product Offered
  12.5.3 JN-International Medical (USA) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 JN-International Medical (USA) News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Vaccine for Non-infectious Meningitis
Table Product Specifications of Vaccine for Non-infectious Meningitis
Figure Vaccine for Non-infectious Meningitis Report Years Considered
Figure Market Research Methodology
Figure Global Vaccine for Non-infectious Meningitis Consumption Growth Rate 2013-2023 (K Units)
Figure Global Vaccine for Non-infectious Meningitis Value Growth Rate 2013-2023 ($ Millions)
Table Vaccine for Non-infectious Meningitis Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Polysaccharide Vaccines
Table Major Players of Polysaccharide Vaccines
Figure Product Picture of Conjugate Vaccines
Table Major Players of Conjugate Vaccines
Figure Product Picture of Combination Vaccines
Table Major Players of Combination Vaccines
Figure Product Picture of Men B Vaccines
Table Major Players of Men B Vaccines
Table Global Consumption Sales by Type (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
Figure Global Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Revenue by Type (2013-2018) ($ million)
Table Global Vaccine for Non-infectious Meningitis Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Vaccine for Non-infectious Meningitis Value Market Share by Type (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Sale Price by Type (2013-2018)
Figure Vaccine for Non-infectious Meningitis Consumed in Meningitis
Figure Global Vaccine for Non-infectious Meningitis Market: Meningitis (2013-2018) (K Units)
Figure Global Vaccine for Non-infectious Meningitis Market: Meningitis (2013-2018) ($ Millions)
Figure Global Meningitis YoY Growth ($ Millions)
Figure Vaccine for Non-infectious Meningitis Consumed in Septicemia
Figure Global Vaccine for Non-infectious Meningitis Market: Septicemia (2013-2018) (K Units)
Figure Global Vaccine for Non-infectious Meningitis Market: Septicemia (2013-2018) ($ Millions)
Figure Global Septicemia YoY Growth ($ Millions)
Figure Vaccine for Non-infectious Meningitis Consumed in Others
Figure Global Vaccine for Non-infectious Meningitis Market: Others (2013-2018) (K Units)
Figure Global Vaccine for Non-infectious Meningitis Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
Figure Global Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Value by Application (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Value Market Share by Application (2013-2018)
Figure Global Vaccine for Non-infectious Meningitis Value Market Share by Application (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Sale Price by Application (2013-2018)
Table Global Vaccine for Non-infectious Meningitis Sales by Players (2016-2018) (K Units)
Table Global Vaccine for Non-infectious Meningitis Sales Market Share by Players (2016-2018)
Figure Global Vaccine for Non-infectious Meningitis Sales Market Share by Players in 2016
Figure Global Vaccine for Non-infectious Meningitis Sales Market Share by Players in 2017
Table Global Vaccine for Non-infectious Meningitis Revenue by Players (2016-2018) ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Revenue Market Share by Players (2016-2018)
Figure Global Vaccine for Non-infectious Meningitis Revenue Market Share by Players in 2016
Figure Global Vaccine for Non-infectious Meningitis Revenue Market Share by Players in 2017
Table Global Vaccine for Non-infectious Meningitis Sale Price by Players (2016-2018)
Figure Global Vaccine for Non-infectious Meningitis Sale Price by Players in 2017
Table Global Vaccine for Non-infectious Meningitis Manufacturing Base Distribution and Sales Area by Players
Table Players Vaccine for Non-infectious Meningitis Products Offered
Table Vaccine for Non-infectious Meningitis Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Vaccine for Non-infectious Meningitis Consumption by Regions 2013-2018 (K Units)
Table Global Vaccine for Non-infectious Meningitis Consumption Market Share by Regions 2013-2018
Figure Global Vaccine for Non-infectious Meningitis Consumption Market Share by Regions 2013-2018
Table Global Vaccine for Non-infectious Meningitis Value by Regions 2013-2018 ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Value Market Share by Regions 2013-2018
Figure Global Vaccine for Non-infectious Meningitis Value Market Share by Regions 2013-2018
Figure Americas Vaccine for Non-infectious Meningitis Consumption 2013-2018 (K Units)
Figure Americas Vaccine for Non-infectious Meningitis Value 2013-2018 ($ Millions)
Figure APAC Vaccine for Non-infectious Meningitis Consumption 2013-2018 (K Units)
Figure APAC Vaccine for Non-infectious Meningitis Value 2013-2018 ($ Millions)
Figure Europe Vaccine for Non-infectious Meningitis Consumption 2013-2018 (K Units)
Figure Europe Vaccine for Non-infectious Meningitis Value 2013-2018 ($ Millions)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Consumption 2013-2018 (K Units)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Value 2013-2018 ($ Millions)
Table Americas Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018) (K Units)
Table Americas Vaccine for Non-infectious Meningitis Consumption Market Share by Countries (2013-2018)
Figure Americas Vaccine for Non-infectious Meningitis Consumption Market Share by Countries in 2017
Table Americas Vaccine for Non-infectious Meningitis Value by Countries (2013-2018) ($ Millions)
Table Americas Vaccine for Non-infectious Meningitis Value Market Share by Countries (2013-2018)
Figure Americas Vaccine for Non-infectious Meningitis Value Market Share by Countries in 2017
Table Americas Vaccine for Non-infectious Meningitis Consumption by Type (2013-2018) (K Units)
Table Americas Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
Figure Americas Vaccine for Non-infectious Meningitis Consumption Market Share by Type in 2017
Table Americas Vaccine for Non-infectious Meningitis Consumption by Application (2013-2018) (K Units)
Table Americas Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
Figure Americas Vaccine for Non-infectious Meningitis Consumption Market Share by Application in 2017
Figure United States Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure United States Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Canada Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Canada Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Mexico Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Mexico Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Table APAC Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018) (K Units)
Table APAC Vaccine for Non-infectious Meningitis Consumption Market Share by Countries (2013-2018)
Figure APAC Vaccine for Non-infectious Meningitis Consumption Market Share by Countries in 2017
Table APAC Vaccine for Non-infectious Meningitis Value by Countries (2013-2018) ($ Millions)
Table APAC Vaccine for Non-infectious Meningitis Value Market Share by Countries (2013-2018)
Figure APAC Vaccine for Non-infectious Meningitis Value Market Share by Countries in 2017
Table APAC Vaccine for Non-infectious Meningitis Consumption by Type (2013-2018) (K Units)
Table APAC Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
Figure APAC Vaccine for Non-infectious Meningitis Consumption Market Share by Type in 2017
Table APAC Vaccine for Non-infectious Meningitis Consumption by Application (2013-2018) (K Units)
Table APAC Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
Figure APAC Vaccine for Non-infectious Meningitis Consumption Market Share by Application in 2017
Figure China Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure China Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Japan Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Japan Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Korea Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Korea Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure India Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure India Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Australia Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Australia Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Table Europe Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018) (K Units)
Table Europe Vaccine for Non-infectious Meningitis Consumption Market Share by Countries (2013-2018)
Figure Europe Vaccine for Non-infectious Meningitis Consumption Market Share by Countries in 2017
Table Europe Vaccine for Non-infectious Meningitis Value by Countries (2013-2018) ($ Millions)
Table Europe Vaccine for Non-infectious Meningitis Value Market Share by Countries (2013-2018)
Figure Europe Vaccine for Non-infectious Meningitis Value Market Share by Countries in 2017
Table Europe Vaccine for Non-infectious Meningitis Consumption by Type (2013-2018) (K Units)
Table Europe Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
Figure Europe Vaccine for Non-infectious Meningitis Consumption Market Share by Type in 2017
Table Europe Vaccine for Non-infectious Meningitis Consumption by Application (2013-2018) (K Units)
Table Europe Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
Figure Europe Vaccine for Non-infectious Meningitis Consumption Market Share by Application in 2017
Figure Germany Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Germany Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure France Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure France Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure UK Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure UK Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Italy Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Italy Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Russia Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Russia Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Spain Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Spain Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Vaccine for Non-infectious Meningitis Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Market Share by Countries in 2017
Table Middle East & Africa Vaccine for Non-infectious Meningitis Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Vaccine for Non-infectious Meningitis Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Value Market Share by Countries in 2017
Table Middle East & Africa Vaccine for Non-infectious Meningitis Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Market Share by Type in 2017
Table Middle East & Africa Vaccine for Non-infectious Meningitis Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Consumption Market Share by Application in 2017
Figure Egypt Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Egypt Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure South Africa Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure South Africa Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Israel Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Israel Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure Turkey Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure Turkey Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Vaccine for Non-infectious Meningitis Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Vaccine for Non-infectious Meningitis Value Growth 2013-2018 ($ Millions)
Table Vaccine for Non-infectious Meningitis Distributors List
Table Vaccine for Non-infectious Meningitis Customer List
Figure Global Vaccine for Non-infectious Meningitis Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Vaccine for Non-infectious Meningitis Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Vaccine for Non-infectious Meningitis Consumption Market Forecast by Regions
Table Global Vaccine for Non-infectious Meningitis Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Value Market Share Forecast by Regions
Figure Americas Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Americas Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure APAC Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure APAC Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Europe Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Europe Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Middle East & Africa Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure United States Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure United States Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Canada Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Canada Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Mexico Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Mexico Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Brazil Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Brazil Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure China Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure China Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Japan Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Japan Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Korea Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Korea Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Southeast Asia Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Southeast Asia Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure India Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure India Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Australia Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Australia Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Germany Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Germany Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure France Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure France Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure UK Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure UK Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Italy Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Italy Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Russia Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Russia Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Spain Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Spain Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Egypt Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Egypt Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure South Africa Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure South Africa Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Israel Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Israel Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure Turkey Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure Turkey Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Figure GCC Countries Vaccine for Non-infectious Meningitis Consumption 2018-2023 (K Units)
Figure GCC Countries Vaccine for Non-infectious Meningitis Value 2018-2023 ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Consumption Forecast by Type (2018-2023) (K Units)
Table Global Vaccine for Non-infectious Meningitis Consumption Market Share Forecast by Type (2018-2023)
Table Global Vaccine for Non-infectious Meningitis Value Forecast by Type (2018-2023) ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Value Market Share Forecast by Type (2018-2023)
Table Global Vaccine for Non-infectious Meningitis Consumption Forecast by Application (2018-2023) (K Units)
Table Global Vaccine for Non-infectious Meningitis Consumption Market Share Forecast by Application (2018-2023)
Table Global Vaccine for Non-infectious Meningitis Value Forecast by Application (2018-2023) ($ Millions)
Table Global Vaccine for Non-infectious Meningitis Value Market Share Forecast by Application (2018-2023)
Table Serum Institute (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Serum Institute (India) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Serum Institute (India) Vaccine for Non-infectious Meningitis Market Share (2016-2018)
Table Sanofi SA (France) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi SA (France) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi SA (France) Vaccine for Non-infectious Meningitis Market Share (2016-2018)
Table Pfizer (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer (USA) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer (USA) Vaccine for Non-infectious Meningitis Market Share (2016-2018)
Table Nuron Biotech (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nuron Biotech (USA) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Nuron Biotech (USA) Vaccine for Non-infectious Meningitis Market Share (2016-2018)
Table JN-International Medical (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table JN-International Medical (USA) Vaccine for Non-infectious Meningitis Sales, Revenue, Price and Gross Margin (2016-2018)
Figure JN-International Medical (USA) Vaccine for Non-infectious Meningitis Market Share (2016-2018)